Trials / Recruiting
RecruitingNCT06412978
Post-Operative Cesarean Section Cosmesis
Post-Operative Cosmesis and Skin Closure Methods After Cesarean Section
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 52 (estimated)
- Sponsor
- Wake Forest University Health Sciences · Academic / Other
- Sex
- Female
- Age
- 18 Years – 44 Years
- Healthy volunteers
- Accepted
Summary
Given the high numbers of cesarean deliveries being performed today, there has been interest in optimizing surgical techniques. Several recent reviews have summarized the evidence for various steps of cesarean delivery, but surprisingly in many cases there is little scientific evidence on which to base the choice of surgical technique.
Detailed description
Cesarean delivery is the most common surgical procedure performed in the United States, with over 1 million procedures performed per year. Based on recent Center for Disease Control (CDC) National Vital Statistics Report (2021) 32.1% of all births in the United States were via cesarean delivery. Given the high numbers of cesarean deliveries being performed today, there has been interest in optimizing surgical techniques. Absorbable staples, made from a combination of polylactic and polyglycolic acid, are a relatively new option for skin closure at the time of surgery. This study is a randomized trial that will investigates two cesarean skin closure techniques-subcuticular, polyglecaprone suture (Monocryl), and absorbable subcuticular polyglycolic acid staples (INSORB)-to determine if one is associated with better scar cosmesis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | absorbable subcuticular polyglycolic acid staples (INSORB) | Insorb absorbable staples are used for skin closure |
| PROCEDURE | subcuticular, polyglecaprone suture (Monocryl) | Monocryl absorbable staples are used for skin closure |
Timeline
- Start date
- 2024-09-05
- Primary completion
- 2026-10-01
- Completion
- 2026-10-01
- First posted
- 2024-05-14
- Last updated
- 2026-03-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06412978. Inclusion in this directory is not an endorsement.